Centessa Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	867	777	293	1,012	-	-
Market Cap Growth	-	165.01%	-71.03%	-	-	-
Enterprise Value	723	605	-31	493	-2	-12
PE Ratio	-8.19	-5.14	-1.36	-2.66	-	-
PS Ratio	126.54	113.40	-	-	-	-
PB Ratio	4.03	3.29	0.87	2.06	-	-
P/FCF Ratio	-7.56	-4.84	-1.45	-7.48	-	-
P/OCF Ratio	-7.57	-4.85	-1.46	-7.49	-	-
EV/Sales Ratio	105.43	88.31	-	-	-	-
EV/EBITDA Ratio	-6.48	-3.66	0.15	-1.30	0.15	-2.45
EV/EBIT Ratio	-6.44	-3.64	0.15	-1.30	0.15	-2.45
EV/FCF Ratio	-6.60	-3.77	0.15	-3.64	0.15	2.13
Debt / Equity Ratio	0.40	0.36	0.21	0.15	1.82	0.30
Debt / EBITDA Ratio	-0.56	-0.51	-0.33	-0.20	-0.53	0.82
Debt / FCF Ratio	-0.57	-0.53	-0.35	-0.56	-0.53	-0.71
Quick Ratio	8.39	6.51	10.27	24.15	0.84	8.58
Current Ratio	10.37	8.00	11.42	25.52	1.30	9.95
Asset Turnover	0.02	0.02	0	0	0	-
Interest Coverage	-15.22	-16.78	-28.81	-324.05	-155.81	-
Return on Equity (ROE)	-56.10%	-56.70%	-53.70%	-80.00%	-127.20%	-
Return on Assets (ROA)	-38.00%	-39.40%	-42.70%	-69.10%	-67.80%	-
Return on Capital (ROIC)	-54.58%	-55.08%	-51.71%	-66.72%	-119.66%	-28.35%
Earnings Yield	-15.96%	-19.44%	-73.73%	-37.64%	-	-
FCF Yield	-17.28%	-20.65%	-68.78%	-13.37%	-	-
Buyback Yield / Dilution	-5.21%	-2.97%	-24.26%	12.52%	-	-
Total Shareholder Return	-5.21%	-2.97%	-24.26%	12.52%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).